Eli Lilly and Company (LLY) Stock: Revenue, Earnings, Margins & Valuation
Eli Lilly and Company (LLY), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Eli Lilly and Company key figures (FY 2025)
| Revenue | 65.18 USD bn |
|---|---|
| Gross profit | 54.13 USD bn |
| Gross margin | 83.0 % |
| Operating income | 20.64 USD bn |
| Operating margin | 31.7 % |
| Net income | 20.64 USD bn |
| Net margin | 31.7 % |
Eli Lilly and Company revenue by segment (FY 2025)
| Segment | Revenue | Share |
|---|---|---|
| Collaboration & Other Revenue | 4.22 USD bn | 6.1 % |
| Mounjaro | 22.97 USD bn | 33.1 % |
| Zepbound | 13.48 USD bn | 19.4 % |
| Trulicity | 4.28 USD bn | 6.2 % |
| Jardiance | 3.43 USD bn | 4.9 % |
| Other Cardiometabolic Health | 4.01 USD bn | 5.8 % |
| Verzenio | 5.72 USD bn | 8.3 % |
| Other Oncology | 3.65 USD bn | 5.3 % |
| Taltz | 3.56 USD bn | 5.1 % |
| Other Immunology | 1.68 USD bn | 2.4 % |
| Neuroscience | 1.39 USD bn | 2.0 % |
| Other Products | 943 USD m | 1.4 % |
Eli Lilly and Company earnings analysis
In the latest reported fiscal year (FY 2025), Eli Lilly and Company generated revenue of 65.18 USD bn. The largest segment is Mounjaro with 22.97 USD bn, about 33.1 % of total segment revenue. From gross margin (83.0 %) through operating margin (31.7 %) to net margin (31.7 %), the Sankey diagram shows how much of each revenue dollar remains at each stage of the income statement.
Eli Lilly and Company business model
The income statement of Eli Lilly and Company is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
More stock analyses like Eli Lilly and Company
- Abbott Laboratories stock (ABT)
- AbbVie Inc. stock (ABBV)
- Advanced Micro Devices stock (AMD)
- Alphabet (Google) stock (GOOGL)
- Amazon.com Inc. stock (AMZN)
- American Express stock (AXP)
- Amgen Inc. stock (AMGN)
- Amphenol Corp. stock (APH)
- Apple Inc. stock (AAPL)
- Applied Materials Inc. stock (AMAT)